ReviewMolecular biology reports2026
Mechanisms and therapeutic potential of AMPK signaling pathway in the regulation of lipid metabolism.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
AMP-activated protein kinase (AMPK) is a central energy sensor that maintains systemic lipid homeostasis. Its therapeutic potential in metabolic diseases, including non‑alcoholic fatty liver disease, atherosclerosis, and obesity, has attracted growing interest. In this review, we systematically summarize the molecular architecture and activation mechanisms of AMPK. We also discuss its tissue‑specific regulatory networks in the liver, adipose tissue, skeletal muscle, macrophages, and the central nervous system. AMPK coordinates metabolic balance through multiple pathways. These include suppression of de novo lipogenesis, enhancement of fatty acid oxidation, modulation of cholesterol metabolism, and promotion of autophagy and lipophagy. We also review the development of AMPK-targeting agents, from natural products to synthetic agonists, and evaluate their therapeutic implications. Collectively, this review provides a conceptual framework for understanding AMPK‑mediated lipid regulation and highlights directions for future investigation.
Indexed as
Identifiers
42536202What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.